Have you ever dropped your new phone and cracked the screen? It’s never a good feeling to lose something of value. Now imagine if that something was worth thousands to millions of dollars and had the potential to change lives. That’s what drug manufacturers stand to lose if a single-use bulk drug storage bag — holding biologic substances — is damaged. A new solution from Gore addresses this issue.

Gore announces the first U.S. implant of the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System. This first case follows the recent FDA approval for this new device.

As the world’s leading brand in the field of new energy automotive materials, W. L. GORE & ASSOCIATES（SHENZHEN）COMPANY LIMITED was one of the conference's VIPs and presented the most advanced scientific and technological achievements to elites in the global new energy vehicle industry.

Single-use systems increasingly need to withstand the rigors of cold chain handling at -40°C to -80°C, particularly for packaging valuable bulk drug product for shipment. Read the article in Genetic Engineering to learn more about how Gore is helping to advance single-use technology in the pharmaceutical space.

Gore will exhibit a wide assortment of high-performance solutions at the 2019 Paris Air Show in France on 17-23 June in Hall 2B, Booth F170. Discover the benefits of Gore’s products and capabilities for air and space applications.

Gore will premier a game-changing cable option for tethered drones used in the military at the 2019 Paris Air Show in France on 17-23 June in Hall 2B, Booth F170.

W. L. Gore & Associates announced the U.S. Food and Drug Administration’s (FDA’s) premarket approval (PMA) of the GORE® CARDIOFORM ASD Occluder for the percutaneous closure of ostium secundum atrial septal defects (ASDs).